BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15101716)

  • 1. Flow cytometric analysis of the expression of Fas/Fasl in bone marrow CD34+ cells in myelodysplastic syndromes: relation to disease progression.
    Ribeiro E; Lima CS; Metze K; Lorand-Metze I
    Leuk Lymphoma; 2004 Feb; 45(2):309-13. PubMed ID: 15101716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
    Zhang Z; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
    Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
    Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.
    Gersuk GM; Beckham C; Loken MR; Kiener P; Anderson JE; Farrand A; Troutt AB; Ledbetter JA; Deeg HJ
    Br J Haematol; 1998 Oct; 103(1):176-88. PubMed ID: 9792306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased apoptosis in mononucleated cells but not in CD34+ cells in blastic forms of myelodysplastic syndromes.
    Berger G; Hunault-Berger M; Rachieru P; Fontenay-Roupie M; Baranger L; Ifrah N; Zandecki M
    Hematol J; 2001; 2(2):87-96. PubMed ID: 11424000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes.
    Ribeiro E; Matarraz Sudón S; de Santiago M; Lima CS; Metze K; Giralt M; Saad ST; de Matos AO; Lorand-Metze I
    Leuk Res; 2006 Jan; 30(1):9-16. PubMed ID: 16005514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia.
    Kitagawa M; Yamaguchi S; Takahashi M; Tanizawa T; Hirokawa K; Kamiyama R
    Leukemia; 1998 Apr; 12(4):486-92. PubMed ID: 9557605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
    Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
    Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.
    Sawanobori M; Yamaguchi S; Hasegawa M; Inoue M; Suzuki K; Kamiyama R; Hirokawa K; Kitagawa M
    Leuk Res; 2003 Jul; 27(7):583-91. PubMed ID: 12681357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival.
    Gupta P; Niehans GA; LeRoy SC; Gupta K; Morrison VA; Schultz C; Knapp DJ; Kratzke RA
    Leukemia; 1999 Jan; 13(1):44-53. PubMed ID: 10049059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in hemopoietic precursors after treatment of low-risk myelodysplasia with amifostine.
    Ribeiro E; Lima CS; Metze K; Souza CA; Lorand-Metze I
    In Vivo; 2003; 17(2):181-4. PubMed ID: 12792983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of G-CSF and GM-CSF receptors on CD34 positive cells in aplastic anemia and myelodysplastic syndrome patients and its significance].
    Xu HZ; Li A; Yu Y; Li JF; Liu X; Wang XH; Wang X; Xu GL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1308-11. PubMed ID: 19099633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
    Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
    Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia.
    Otawa M; Kawanishi Y; Iwase O; Shoji N; Miyazawa K; Ohyashiki K
    Leuk Res; 2000 Apr; 24(4):359-66. PubMed ID: 10713334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Four-color flow cytometric immunophenotypic features of blasts in myelodysplastic syndromes].
    Wu YJ; Li JY; Qiu HR; Xiao B; Zhang JF; Song JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):50-3. PubMed ID: 16584591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry.
    Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A
    Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of Thy-1 expression in myelodysplastic syndrome.
    Inaba T; Shimazaki C; Sumikuma T; Shimura K; Takahashi R; Hirai H; Ashihara E; Sudo Y; Murakami S; Haruyama H; Fujita N; Yoshimura M; Nakagawa M
    Int J Hematol; 1998 Dec; 68(4):403-10. PubMed ID: 9885439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute number of circulating CD34+ cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t; novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry.
    Fuchigami K; Mori H; Matsuo T; Iwanaga M; Nagai K; Kuriyama K; Tomonaga M
    Leuk Res; 2000 Feb; 24(2):163-74. PubMed ID: 10654453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive expression of the Fas receptor and its ligand in adult human bone marrow: a regulatory feedback loop for the homeostatic control of hematopoiesis.
    Brazil JJ; Gupta P
    Blood Cells Mol Dis; 2002; 29(1):94-103. PubMed ID: 12482410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of CD133 in the bone marrow of patients with myelodysplastic syndrome and its clinical significance].
    Zhong LY; DU X; Geng SX; Weng JY; Zheng HT; Wu SJ; Li YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):854-5. PubMed ID: 21602141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.